Retractable Technologies - A Top 100 Stock
Long Only, Momentum, Portfolio Strategy
Seeking Alpha Analyst Since 2009
Jim Van Meerten writes on financial subjects here and on Barchart Portfolio Blogs and Seeking Alpha. He earned a BS in Accounting and Business Administration from Berry College; a Juris Doctorate from the Woodrow Wilson School of Law; and attended post-baccalaureate and graduate courses in Business Administration, Quantitative Math, and Education at Florida Atlantic University, Georgia State University and University of North Carolina at Charlotte. In the past he has been an accountant, attorney, adjunct professor in Business Law, Accounting and Internal Auditing, financial advisor, supervisory principal, and compliance officer. He also passed the Georgia CPA Exam, the Certified Internal Auditor Exam, and the FINRA Series 7, 24 and 9/10 exams.He is presently also a contributor on MSN Top Stocks Blog, Motley Fool and is a member of the M100 on Marketocracy, an elete honor chosen by the editors of Marketocracy as being in the top 100 portfolio managers of over 100,000 portfoiios they review. He would enjoy hearing your comments at JimVanMeerten@gmail.com.
Summary
- 100% technical buy signals.
- 5 new highs and up 27.51% in the last month.
- 1,219.04% gain in the last year.
The Barchart Chart of the Day belongs to the specialty safety syringe company Retractable Technologies (RVP). I found the stock by sorting Barchart's Top 100 Stocks list by the highest Weighted Alpha, then used the Flipchart function to review the charts for consistent price appreciation. Since the Trend spotter signaled a buy in 6/24 the stock gained 29.97%.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, autodisable, and allergy antigen syringes; IV catheters; blood collection tube holders; blood collection sets; and Patient Safe safety medical products, including syringes and Luer caps. The company also engages in developing retractable needles and syringes, glass syringes, dental syringes, IV catheter introducers, and blood collection sets, as well as EasyPoint needles. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.
Barchart technical indicators:
- 100% technical buy signals
- 488.30+ Weighted Alpha
- 1,219.04% gain in the last year
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 5 new highs and up 27.51% in the last month
- Relative Strength Index 64.62%
- Technical support level at 9.40
- Recently traded at 9.41 with a 50 day moving average of 6.50
Fundamental factors:
- Market Cap $340 million
- P/E 101.11
- This stock is not followed by Wall Street analysts so we don't have Revenue and Earnings projections
- The individual investors following the stock on Motley Fool vote 6 to 0 that the stock will beat the market
- 1,640 investors are monitoring the stock on Seeking Alpha
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.